• Türkçe
  • English
Course Code: 
MDP 220
Course Period: 
Autumn
Course Type: 
Core
P: 
3
Lab: 
0
Credits: 
3
ECTS: 
4
Course Language: 
English
Course Objectives: 
The goals of this course are; • to remind knowledge on structures of agents that cause infectious clinical conditions which are frequent in community and/or pose high risk for individual or community health, and/or life-threatening or constitute an emergency, • to convey knowledge on pathogenesis mechanisms of agents that cause infectious clinical conditions which are frequent in community and/or pose high risk for individual or community health, and/or life-threatening or constitute an emergency, • to convey necessary knowledge on prevention of infectious clinical conditions, and protection or • improvement of health against these conditions, • to convey necessary knowledge on pharmacology of drugs used in infectious clinical conditions which are frequent in community and/or pose high risk for individual or community health, and/or life-threatening or constitute an emergency,
Course Content: 

Basic Microbiology, Medical Microbiology, Infectious Diseases.

Course Methodology: 
1: Lecture
Course Evaluation Methods: 
A: Written Exam (Multiple Choice Questions)

Vertical Tabs

Course Learning Outcomes

Learning Outcomes

At the end of this coourse, student should be able to:

Program

Outcomes

Teaching

Methods

Assessment Methods

Describe bacterial classification:

  • List taxon levels
  • Define taxonomy and identification
  • Describe principles of taxonomy
  • Explain classification of bacteria

5, 7, 12, 13

1

A

Explain growth and cultivation of bacteria:

  • define “microbial growth” and “microbial cultivation"
  • list the stages/phases of microbial growth
  • list the types or forms of microbial growth (including planktonic, colonial, biofilm)  
  • list the common nutrient requirements
  • list the  growth factors
  • list the major “nutritional types of microorganisms”
  • list the basic metabolic pathways of microorganisms
  • define “microbial culture” and “culture medium”
  • describe the types of culture media
  • explain the value of “pure culture” for diagnostic procedures
  • define “colony forming unit”
  • list culture techniques and conditions

5, 7, 12, 13

1

A

Describe bacterial pathogenesis:

  • define the basic concepts of infection (infectious cycle/transmission chain, infectious disease,  communicable disease, transmissible disease, transmission routes, adherence, invasion, toxigenicity, infectious dose, carrier)
  • define the pathogen factors that contributes to host-pathogen interaction (symbiotic relations, pathogenic/opportunistic/non-pathogenic microorganism, pathogenicity, virulence, virulence factors)
  • explain the importance of virulence factors in tissue destruction
  • describe the pathological consequences of infection and its impact on clinical course
  • explain the probable clinical courses and factors effective on outcomes of infectious diseases (recovery, immunity, immune deficiency, persistance,  reactivation, autoimmunity, malignancy, mortality)

5, 7, 12, 13

1

A

Explain bacterial genetics:

  • explain basics of nucleic acid function (replication of DNA, chromosome replication, DNA repair, gene expression, gene organization) in bacteria
  • describe sources of mutation and variation in bacteria
  • describe basic features of bacteriophages and plasmids
  • describe mechanisms of gene transfer in bacteria
  • explain the importance of genomic plasticity in bacteria

5, 7, 12, 13

1

A

Describe gram positive cocci:

  • list gram positive cocci
  • tell the clinical importance of gram positive cocci
  • describe common characteristics of gram positive cocci
  • describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of medically important gram positive cocci

5, 7, 12, 13

1

A

Explain sterilization and disinfection:

  • tell the conventional and technical definitions of antisepsis, decontamination/cleaning, disinfection and sterilization,
  • tell the definitions of germicide, sporicide, low-/intermediate-/high-level disinfectant, sterilant. 
  • classify infectious agents according to resistance level against disinfectants.
  • classify medical devices based on pre-market regulation, infectious risk and reprocessing procedure.
  • describe methods of sterilization, disinfection and antisepsis. 

5, 7, 12, 13

1

A

Decsribe enteric gram negative bacilli:

  • tell the definition of enteric bacteria,
  • tell the clinical importance of enteric bacteria,
  • describe common characteristics of Enterobacteriaceae,
  • describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of medically important Enterobacteriaceae  (Citrobacter spp., Enterobacter spp., Escherichia coli, Klebsiella spp., Morganella morganii, Proteus spp., Salmonella enterica, Serratia marcescens, Shigella spp., Yersinia spp.)

 

5, 7, 12, 13

1

A

Describe antibacterial agents:

  • tell the definitions of antibiotic, antimicrobial, antimicrobial spectrum, selective toxicity, antibacterial, bactericidal effect, bacteriostatic effect, antimicrobial combination, synergy, addivity, antagonism, antimicrobial susceptibility and resistance.
  • classify the mechanisms of antibacterial effect
  • describe mechanisms of effect and resistance for antibacterials that act by cell-wall inhibition
  • describe mechanisms of effect and resistance for antibacterials that act by inhibition of protein synthesis
  • describe mechanisms of effect and resistance for antibacterials that act by inhibition of nucleic acid synthesis
  • describe mechanisms of effect and resistance for antibacterials that act by increase in cell-membrane permeability

 

5, 7, 12, 13

1

A

Explain gram negative cocci:

  • list gram negative cocci
  • tell the clinical importance of gram negative cocci
  • describe common characteristics of gram negative cocci
  • describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of medically important gram negative cocci

 

1

A

Describe Yersinia, Francisella, Pasteurella, Vibrio, Campylobacter:

  • tell the clinical importance of these bacteria
  • describe common characteristics of these bacteria
  • describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of medically important these bacteria

5, 7, 12, 13

1

A

Describe Spirochetes:

  • list these bacteria
  • tell the clinical importance of these bacteria
  • describe common characteristics of these bacteria
  • describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of medically important these bacteria

 

1

A

Define Mycobacteria:

  • tell the clinical importance of mycobacteria
  • describe common and differential characteristics of mycobacteria
  • describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of medically important mycobacteria (M. tuberculosis, M. leprae, M. avium complex)

5, 7, 12, 13

1

A

Describe Actinomyces, Nocardia:

  • tell the clinical importance of Actinomyces, Nocardia
  • describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of Actinomyces, Nocardia

5, 7, 12, 13

1

A

Describe Mycoplasma, Chlamidya, Rickettsia:

  • tell the clinical importance of Mycoplasma, Chlamidya, Rickettsia 
  • describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of Mycoplasma, Chlamidya, Rickettsia

5, 7, 12, 13

1

A

Describe anaerobic bacteria:

  • tell the clinical importance of anaerobic bacteria
  • describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of anaerobic bacteria (anaerobic/non-spore-forming Gram-positive bacteria:
  • Gram-positive cocci and rods -Actinomyces, Mobiluncus, Lactobacillus, Propionibacterium-; anaerobic/spore-forming Gram-positive rods -Clostridium perfringens, Clostridium tetani, Clostridium botulinum,  Clostridium difficile-; anaerobic/non-spore-forming Gram-negative bacteria: -Bacteroides,  Porphyromonas, Prevotella-)

 

5, 7, 12, 13

1

A

Describe DNA viruses:

  • list these viruses
  • tell the clinical importance of these viruses
  • describe common and unique characteristics of these viruses
  • describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of medically important these viruses

5, 7, 12, 13

1

A

Describe RNA viruses:

  • list these viruses
  • tell the clinical importance of these viruses
  • describe common and unique characteristics of these viruses
  • describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of medically important these viruses

5, 7, 12, 13

1

A

Explain general principles of mycology:

  • Explain fungal classification
  • Describe fungal structure, growth and cultivation
  • Tell the clinical importance of fungi
  • Describe common and unique characteristics of fungi
  • Describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of medically important fungi

5, 7, 12, 13

1

A

Explain general principles of parasitology:

  • Explain the classification of parasites
  • Describe basic structure, growth and life cycle of parasites
  • Tell the clinical importance of parasites
  • Describe common and unique characteristics of parasites
  • Describe biology, pathogenesis, virulence, diseases, epidemiology, diagnosis, treatment,  prevention and control of medically important parasites

5, 7, 12, 13

1

A

 
 

Course Flow

Week

Topics

Study Materials

1

Bacterial classification

Growth and cultivation of bacteria

1, 2

2

Bacterial pathogenesis

Bacterial genetics

1, 2

3

Gram positive cocci

Sterilization and disinfection

1, 2

4

Mid-term exam

1, 2

5

Enteric gram negative bacilli

1, 2

6

Antibacterial agents

1, 2

7

Gram negative cocci

Yersinia, Francisella, Pasteurella, Vibrio, Campylobacter

1, 2

8

Spirochetes

Mycobacteria

1, 2

9

Actinomyces, Nocardia

Mycoplasma, Chlamidya, Rickettsia

1, 2

10

DNA viruses

1, 2

11

RNA viruses

1, 2

12

Introduction to mycology

1, 2

13

Introduction to parasitology

1, 2

14

Final Exam

1, 2

 
 

Recommended Sources

Textbook

Medical Microbiology (Medical Microbiology (Murray)) [Paperback] Patrick R. Murray PhD (Author), Ken S. Rosenthal PhD (Author), Michael A. Pfaller MD (Author) Publication Date: December 24, 2008 | ISBN-10: 0323054706 | ISBN-13: 978-0323054706 | Edition: 6

Additional Resources

Lecture handouts

 
 

Material Sharing

Documents

Lecture handouts

Assignments

None

Exams

Mid-term, Final

 
 

Assessment

IN-TERM STUDIES

NUMBER

PERCENTAGE

Mid-term examination

1

100

Total

 

100

CONTRIBUTION OF FINAL EXAMINATION TO OVERALL GRADE

 

60

CONTRIBUTION OF IN-TERM EXAMINATION TO OVERALL GRADE

 

40

Total

 

100

 

 

COURSE CATEGORY

Expertise/Field Courses

 
 

Course’s Contribution to Program

No

Program Learning Outcomes

Contribution

1

2

3

4

5

1

Acquire skills needed to practice the profession of pharmacy in either a Turkish or an English language setting.

X

       

2

Being equipped to access current theoretical and applied knowledge, keeping abreast of new developments, and possessing the critical faculties enabling an accurate and reliable interpretation and assessment of this information.

 

X

     

3

Having the capacity to apply the skills acquired in the field of pharmaceutical science. Possessing the ability to harness his/her acquired knowledge in order to function as a highly accessible health counsellor, providing a ready source of clinically relevant, health-related information to the general public.

   

X

   

4

Keeping abreast of and being equipped to apply the fundamental pharmaceutical and health science principles which guide future developments in modern technology, and being able to share these experiences and skills with colleagues through participatation in professional development education seminars.

   

X

   

5

Knowing how to assess risks arising from the use of drugs and other chemicals and those risks potentially encounterd during laboratory practice.

       

X

6

Acquiring the skills and knowledge needed to interpret findings obtained through quantative and qualitative measurements, and thus reach valid, scientific conclusions based on this data. 

 

X

     

7

Being able to compound pharmaceutical products while being knowledgable about their clinical application, interactions, side effects and risks  and apply in proper manner .

     

X

 

8

Being competent to conduct and manage research and development projects, and share experimental outcomes.

X

       

9

Be competent to accurately and intelligibly communicate clincally relevant information to patients concerning prescription items and other pharmaceutical products.  

   

X

   

10

Being able to function in a multidisciplinary environment. Possessing the skill to collaborate and establish lines of communication with other professionals, while developing their own professional competency through participation in relevant continuing education activities.

 

X

     

11

Being able to play a role in projects which fulfills the profession’s societal responsibilities. Participating in professional activities and undertaking duties in a manner which reflects an awareness of and sensitivity to environmental issues.

X

       

12

Being capable of opening a community pharmacy, practicing in a hospital pharmacy setting, and offering service in any field related to drugs, cosmetics, medical  and/or plant-derived products. Able to play an active role in his/her own personal professional development, as well as that of colleagues and pharmaceutical students.

 

 

 

 

X

13

Able to play a role in issues related to public health as a member of the health care team while being cognizant of and able to fulfill legal and professional requirements and maintain ethical standards. 

 

 

 

 

X

14

Is knowledgable of and equipped to manage the planning, development, compounding and quality control analysis of naturally occuring and synthetic medicines, while also being aware of the processes related to these products’ absorption, distribution, metabolism and excretion from the body.

 

 

X

 

 

 
 

ECTS

Activities

Quantity

Duration
(Hour)

Total
Workload
(Hour)

Lectures

12

3

36

Independent study

14

3

42

Mid-term examination

1

10

10

Final examination

1

10

10

Total Work Load

 

 

98

Total Work Load / 25 (h)

 

 

3,9

ECTS Credit of the Course

 

 

4